Compare TransMedics Group Inc (TMDX) vs Vanguard Total Stock Market Index Fund ETF (VTI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TransMedics Group Inc vs Vanguard Total Stock Market Index Fund ETF — how do they compare? TransMedics Group Inc trades at $86.4 (market cap $3.00B), while Vanguard Total Stock Market Index Fund ETF trades at $376.51. The key difference: Vanguard Total Stock Market Index Fund ETF is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals.
| TMDX | VTI | |
|---|---|---|
Market Cap | $3.00B | — |
Sector | Technology | — |
52-Week High | $150.42 | $384.30 |
52-Week Low | $61.99 | $311.68 |
Enterprise Value | $3.39B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TransMedics Group (TMDX) trades at $88.27, down 1.9% on the day, with a bullish technical signal from moving averages but mixed earnings results. The company reported strong revenue growth to $605.49M in 2025, with a net income margin of 22.69%, though profitability is expected to moderate in 2026. Recent news highlights ongoing legal investigations into fiduciary duties alongside positive coverage of growth initiatives in kidney transplantation and European expansion.
The stock presents a growth opportunity with analyst consensus pointing to a $99.57 price target, but risks include margin pressure from heavy investments and legal uncertainties. Earnings misses in recent quarters and a projected decline in net income for 2026 warrant caution, though institutional interest remains with a bullish rating from 69% of analysts.
VTI trades at $377.6, down 0.56% on the day, with a neutral technical signal. The ETF offers broad U.S. stock market exposure across 3,515 companies. Recent news highlights its role in diversified portfolios, with institutional buying noted. Moving averages show a bullish trend, while oscillators are neutral, indicating mixed short-term momentum.
Long-term outlook remains positive given historical market returns, but concentration risk exists with top holdings. Key risks include market volatility and economic downturns. Analyst sentiment is generally favorable for buy-and-hold strategies, emphasizing low costs and diversification.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →About Vanguard Total Stock Market Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the index, which represents approximately 100% of the investable US stock market and includes large-, mid-, small-, and micro-cap stocks. It invests by sampling the index, meaning that it holds a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.
Read more on VTI →
